C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways. J Appl Oral Sci [Internet]. 2023 Feb. 6 [cited 2024 Jun. 14];31:e20220404. Available from: https://www.periodicos.usp.br/jaos/article/view/207724